Abstract:Abstract The increasing prevalence of depression and diabetes mellitus has become a major public health problem worldwide. Studies have shown that people with diabetes are at a high risk of being diagnosed with depression, and diabetes complicates depression treatment by promoting the deterioration of glycemic control, reducing self-care ability and quality of life, and causing severe functional disability and early mortality. Moreover, health deterioration dramatically increases the financial cost of social and health care system. Thus, how to treat depression, diabetes, and diabetes complicated by depression has become one of the world’s urgent concerns. The activation of nod-like receptor family pyrin domain containing 3 (NLRP3) is closely related to mental illness. This finding provides a new perspective for studying depression. NLRP3 plays an important role in the development of diabetes. In this review, we elaborate the definition and epidemiology of depression, diabetes, and diabetic depression and introduce the functional characteristics of an NLRP3 inflammasome and upstream P2X7 receptor. Moreover, related research on NLRP3 inflammasomes and P2X7 receptors is summarized and used as a reference for confirming that the excessive activation of P2X7- NLRP3 leads to the increased release of inflammatory cytokines, such as IL-1β, in depression and diabetes. We provide insights into the P2X7–NLRP3–IL-1β pathway as an important pathological mechanism and novel therapeutic target in diabetes and depression. Given that the P2X7–NLRP3–IL-1β pathway may play an important role in diabetes confounded by comorbid depression, the possibility of intervention with baicalin is proposed.

Research progress on the relationship between NLRP3 inflammatory body and depression

The NLRP3 inflammasome in depression: Potential mechanisms and therapies

NLRP3 inflammatory pathway. Can we unlock depression?

Research progress of neuroendocrine immune inflammation in depression

Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression

Autophagy dysfunction contributes to NLRP1 inflammasome-linked depressive-like behaviors in mice

Research progress on the effect of Nrf2-mediated signaling pathway on inflammatory response and oxidative stress in major depressive disorder

Tert-Butylhydroquinone Prevents Neuroinflammation and Relieves Depression Via Regulation of NLRP3 Signaling in Mice

Association between neutrophil-to-lymphocyte ratio and specific depressive symptoms: an analysis of a population-based cross-sectional survey

Research Progress on Natural Compounds Exerting an Antidepressant Effect through Anti-inflammatory

A new perspective on depression and neuroinflammation: Non-coding RNA

P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes

Nlrp3 Inflammasome Mediates Chronic Mild Stress-Induced Depression in Mice Via Neuroinflammation

Neuroimmune Advance in Depressive Disorder

Research Progress of Immune Regulation in Antidepressant Treatment

Progress of neuroinflammation mechanism in depression

Reseach progress in neuroinflammation mechanism in depression.

Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic Strategies

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update

The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-naïve major depressive disorder

P2RY12 Increased Neuroinflammation to Accelerate Depression-like Behaviors by the NLPR3 Inflammasome